1. Enflurane package insert, Ohio Medical Products Canada (1975).
2. Botty, C., Brown, B., Stanley, V., &Stephen, C.R. Clinical experiences with compound 347, a halogenated anaesthetic compound. Anaesthesia and Analgesia47: 499 (1968).
3. Burchiel, K.J., Stockard, J.J., Myers, R.R., Smith, N.T., &Calverley, R.K. Epileptogenicity of enflurane and isoflurance in man and cats: relative effects of Paco 2 on intersuppression activity and seizure duration. Abstracts of Scientific Papers, ASA annual meetings, Washington, D.C., p. 159 (October 1974).
4. Ohm, W.W., Cullen, B.F., Amory, D.W., &Kennedy, R.D. Delayed activity following Enflurane anaesthesia. Anaesthesiology42: 367 (1975).
5. Linde, H.W., Lamb, V.E., Quimby, C.W., Homi, J., &Eckenhoff, J.E. The search for better anaesthetic agents: clinical investigation of ethrane. Anaesthesiology32: 555 (1970).